Get started
EDWARDS LIFEDRNEDWARDS LIFEDRNEDWARDS LIFEDRN

EDWARDS LIFEDRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

E1WL34 chart


Full chart

Key facts today


Edwards Lifesciences gained CE mark approval for its Sapien M3 mitral valve replacement system, targeting patients with symptomatic mitral regurgitation unsuitable for surgery or other therapies.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪238.99 B‬ BRL
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
30,696.97
Basic EPS (TTM)
0.00 BRL
Net income (FY)
‪4.71 B‬ BRL
Revenue (FY)
‪29.32 B‬ BRL
Shares float
—
Beta (1Y)
0.31

About Edwards Lifesciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Bernard J. Zovighian
Website
edwards.com
Headquarters
Irvine
Founded
1958
ISIN
BRE1WLBDR000
FIGI
BBG00RD62B78
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

E1WL34 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

E1WL34 highest yielding bonds


US28176EAD0
EDWARDS LIFE. 18/28
Yield to maturity
5.18%
Maturity date
Jun 15, 2028

See all E1WL34 bonds 


Check out other big names from the same industry as E1WL34.